About This Event
Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, David P. Luci, President & Chief Executive Officer, rings the Closing Bell.